While the tumultuous year that was 2020 brought numerous unforeseen challenges with it, psychedelic medicine made remarkable progress. With the new year in full swing, psychedelic companies are continuing to make their debut on the stock exchanges, making their mark on capital markets. After a fortuitous conference series in 2020, Psychedelic Capital, the premiere psychedelic due diligence conference, returns to highlight dignitaries from the top companies in the space.
The First Psychedelic Capital of 2021 Features Innovative Sponsors and Speakers
The first Psychedelic Capital event of 2021 is on January 28th at 4:30pm EST and will feature engaging presentations from our sponsors, Psygen Labs, Albert Labs and Mindset Pharma.